Regulatory reform is rising on global policy agendas. Yet while this regulatory reform agenda promises relief for firms, it ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

Nordic Capital and Riverside see investment opportunities in interoperability, automation and compliance software for global ...

Empower Pharmacy markets itself as a well-meaning rival to Big Pharma - one that seeks to democratize medicine by making ...

Pakistan Single Window (PSW) has integrated key export-related services of the Drug Regulatory Authority of Pakistan (DRAP) into its digital platform, ...

The legalization of adult-use cannabis across numerous U.S. states was driven by more than economic or regulatory motivations ...

The global industrial vacuum cleaner market share analysis has evolved beyond simple functionality, becoming a highly ...

Drug companies and specialty distributors navigate challenges like profitability, supply chain volatility, regulatory complexities, and market pressures to build successful partnerships, said Natalie ...

Alleging that medicines are increasingly being routed into Karnataka from external markets through unauthorised distribution ...

This week, underscoring a commitment to national security, the White House and the Food and Drug Administration (FDA) issued ...